Kagamu H - Search Results

1

Anti-interferon-gamma autoantibody in a patient with disseminated Mycobacterium avium complex.

Koya T, Tsubata C, Kagamu H, Koyama K, Hayashi M, Kuwabara K, Itoh T, Tanabe Y, Takada T, Gejyo F. Koya T, et al. Among authors: kagamu h. J Infect Chemother. 2009 Apr;15(2):118-22. doi: 10.1007/s10156-008-0662-8. Epub 2009 Apr 25. J Infect Chemother. 2009. PMID: 19396523

2

Clinicopathological impact of VEGFR2 and VEGF-C in patients with EGFR-major mutant NSCLC receiving osimertinib.

Kaira K, Imai H, Mouri A, Hashimoto K, Miura Y, Shiono A, Yamaguchi O, Kobayashi K, Kawasaki T, Yasuda M, Kagamu H. Kaira K, et al. Among authors: kagamu h. Thorac Cancer. 2023 Oct;14(29):2950-2961. doi: 10.1111/1759-7714.15082. Epub 2023 Aug 22. Thorac Cancer. 2023. PMID: 37605832 Free PMC article.

3

Potential of VEGFR2 expression as a predictive marker of PD‑1 blockade in patients with advanced NSCLC.

Kaira K, Imai H, Kawasaki T, Hashimoto K, Miura Y, Shiono A, Yamaguchi O, Mouri A, Kobayashi K, Yasuda M, Kagamu H. Kaira K, et al. Among authors: kagamu h. Oncol Rep. 2022 Dec;48(6):214. doi: 10.3892/or.2022.8429. Epub 2022 Oct 25. Oncol Rep. 2022. PMID: 36281948 Free PMC article.

4

Tumor response like pseudo-progression to lenvatinib in advanced thymic carcinoma.

Ito K, Yamaguchi O, Kaira K, Imai H, Kagamu H. Ito K, et al. Among authors: kagamu h. Lung Cancer. 2023 May;179:107193. doi: 10.1016/j.lungcan.2023.107193. Epub 2023 Apr 10. Lung Cancer. 2023. PMID: 37058785 No abstract available.

5

Author Correction: A retrospective analysis of tumor infiltrating lymphocytes in head and neck squamous cell carcinoma patients treated with nivolumab.

Kuba K, Inoue H, Matsumura S, Enoki Y, Kogashiwa Y, Ebihara Y, Nakahira M, Yamazaki T, Yasuda M, Kaira K, Kagamu H, Sugasawa M. Kuba K, et al. Among authors: kagamu h. Sci Rep. 2023 Jan 26;13(1):1472. doi: 10.1038/s41598-023-28598-w. Sci Rep. 2023. PMID: 36702866 Free PMC article. No abstract available.

6

Prognostic significance of tumor infiltrating lymphocytes on first-line pembrolizumab efficacy in advanced non-small cell lung cancer.

Kaira K, Yamaguchi O, Kawasaki T, Hashimoto K, Miura Y, Shiono A, Mouri A, Imai H, Kobayashi K, Yasuda M, Kagamu H. Kaira K, et al. Among authors: kagamu h. Discov Oncol. 2023 Jan 20;14(1):6. doi: 10.1007/s12672-023-00615-4. Discov Oncol. 2023. PMID: 36662367 Free PMC article.

7

Expression of hormone receptors is associated with specific immunological profiles of the breast cancer microenvironment.

Hanamura T, Kitano S, Kagamu H, Yamashita M, Terao M, Okamura T, Kumaki N, Hozumi K, Iwamoto T, Honda C, Kurozumi S, Niikura N. Hanamura T, et al. Among authors: kagamu h. Breast Cancer Res. 2023 Jan 31;25(1):13. doi: 10.1186/s13058-023-01606-7. Breast Cancer Res. 2023. PMID: 36721218 Free PMC article.

8

Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer.

Wasamoto S, Imai H, Tsuda T, Nagai Y, Minemura H, Yamada Y, Umeda Y, Kishikawa T, Shiono A, Kozu Y, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Minato K, Kagamu H. Wasamoto S, et al. Among authors: kagamu h. Front Oncol. 2023 Jan 20;12:1080729. doi: 10.3389/fonc.2022.1080729. eCollection 2022. Front Oncol. 2023. PMID: 36741711 Free PMC article.

9

Comparative analysis of different response criteria at early phase after PD-1 blockade in non-small lung cancer.

Kaira K, Yamaguchi O, Naruse I, Umeda Y, Honda T, Watanabe S, Ichikawa K, Yanagisawa S, Kasahara N, Higuchi T, Hashimoto K, Miura Y, Shiono A, Mouri A, Imai H, Iizuka K, Ishizuka T, Minato K, Suda S, Kagamu H, Mori K, Seki N, Kuji I. Kaira K, et al. Among authors: kagamu h. Cancer Imaging. 2023 Mar 1;23(1):23. doi: 10.1186/s40644-023-00538-x. Cancer Imaging. 2023. PMID: 36859341 Free PMC article.

10

A retrospective analysis of tumor infiltrating lymphocytes in head and neck squamous cell carcinoma patients treated with nivolumab.

Kuba K, Inoue H, Matsumura S, Enoki Y, Kogashiwa Y, Ebihara Y, Nakahira M, Yamazaki T, Yasuda M, Kaira K, Kagamu H, Sugasawa M. Kuba K, et al. Among authors: kagamu h. Sci Rep. 2022 Dec 29;12(1):22557. doi: 10.1038/s41598-022-27237-0. Sci Rep. 2022. PMID: 36581686 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

195 results

Search Page

Filters